View Older Stories View More Recent Stories
-
ChinaCache (CCIH) CFO Resigns; Interim Appointee Named
-
ChinaCache Announces Change of Management
-
Roth Capital Resumes Callaway Golf (ELY) at Buy
-
Great Basin Scientific (GBSN) Enters Securities Purchase Agreement for $75M of Conv. Senior Notes
-
Great Basin Secures $75 Million Funding Commitment in Senior Convertible Notes
-
Roth Capital Says Chinese Bus Programs Remain Important for Ballard Power (BLDP); Affirms at 'Buy'
-
RGS Energy (RGSE) Announces Common Stock Offer
-
Real Goods Solar Announces Public Offering of Units
-
Roth Maintains Unique Fabricating (UFAB) at 'Buy'; Thesis Affirmed Following 8-K Filing
-
Roth Sees Limited Use of Cytori's (CYTX) Cell Therapy in Japan as Key Milestone; Affirms at 'Buy'
-
Roth Affirms SolarCity (SCTY) at 'Neutral' Amid Tesla's (TSLA) Move to Acquire the Company; Says Many Questions Remain
-
Roth Capital Reinstates Alcobra Ltd. (ADHD) at Buy
-
Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock
-
Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
-
Notable Mergers and Acquisitions 6/21: (IPXL) (OSIS)/(ASEI) (TCEHY) (PHG)
-
OSI Systems (OSIS) to Acquire AS&E (ASEI) in Net $187M Deal
-
OSI Systems Enters into Definitive Agreement to Acquire American Science and Engineering
-
Roth Capital Starts Heat Biologics (HTBX) at Buy
-
Canadian Solar to Participate in ROTH Capital Partners Cleantech & Industrial Growth Day in London
-
Roth Lowers Ests on Sky Solar (SKYS) Following Mixed Q1 Results; Affirms at 'Buy'
-
Roth Capital Starts PhaseRx (PZRX) at Buy
-
Renewable Energy Group to Participate in the ROTH Capital Partners Cleantech & Industrial Growth Day
-
Roth Capital Remains Bullish on Capricor Therapeutics (CAPR) Following Strong CAP-1002 Data in AHF
-
Roth Capital Resumes Ohr Pharmaceutical (OHRP) at 'Buy'; Believes Market Undervaluing Potential
-
Tonix Pharmaceuticals (TNXP) Prices 5M Common Stock Offering at $2/Share
-
Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock
-
Tonix Pharmaceuticals (TNXP) Announces Common Stock Offering
-
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Roth Capital Starts Vista Outdoor (VSTO) at Buy
-
Roth Capital Starts Capricor Therapeutics (CAPR) at Buy
-
Roth Capital Lifts PT on Yingli Green Energy (YGE) to $3.50; Q1 Not Bad, but Challenges Remain
-
Ameresco to Participate in ROTH Capital Partners Cleantech & Industrial Growth Day on June 21 in London
-
Dataram (DRAM) Enters Agreement to Acquire US Gold Corp.
-
Dataram Enters into Definitive Agreement to Acquire US Gold Corp
-
Pieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
-
ROTH Capital Partners to Host 3rd Annual Healthcare Day in London on June 22, 2016
-
Roth Capital Upgrades Aptose Biosciences (APTO) to Buy
-
Roth Trims PT on Capstone Turbine (CPST) Amid Q4 Report; Sees More Aggressive FH2'17
-
Roth Affirms FuelCell (FCEL) at 'Buy' Following Q2 Results; ITC Remediation Becoming Increasingly Important
-
Roth Expects Inline Q4 Results from Capstone Turbine (CPST), But Thinks Order Momentum Will be Key
-
Roth Capital Trims PT on BioBlast (ORPN) to $15; New Focus is Tough, But Necessary, Decision
-
Roth Capital Doesn't See FuelCell's (FCEL) Q2 Report as Eventful, but Expects Key Updates
-
Roth Affirms Fibrocell Science (FCSC) at 'Buy' Following Azficel-T Phase 2 Miss in Vocal Cord Scarring
-
Pieris Pharmaceuticals Announces Closing of $16.5 Million Private Placement
-
Roth Sees Positive Read-Through on Power Solutions (PSIX) Following Results from Navistar (NAV); Boosts PT to $23
-
Ocean Power Technologies (OPTT) Closes Common Stock, Warrants Direct Offering
-
Ocean Power Technologies Announces Closing of Registered Direct Public Offering of Common Stock and Warrants
-
Challenged Athletes Foundation Celebrates A Decade Of Difference At A Celebration Of Heroes, Heart And Hope Gala
-
Delcath Systems (DCTH) Issues $35M in Senior Convertible Notes
-
Delcath Issues $35 Million in Senior Convertible Notes to Support Melphalan/HDS Clinical Development and CHEMOSAT European Commercialization
